Indian pharmaceutical giant Wockhardt is currently in merger talks. The company, known for its extensive portfolio of generic and branded drugs, has been facing difficulties in recent years. Sources close to the transaction suggest that Wockhardt is {attracting interest from|being courted by both domestic and international firms. A final decision i